Regulatory

Institutional Biosafety Committee

Provecta Research Network conducts clinical research, including studies involving recombinant or synthetic nucleic acid molecules. That research is overseen by an Institutional Biosafety Committee (IBC), as required by the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.

Our IBC

Provecta's IBC is administered by WCG Clinical, Inc. and registered with the National Institutes of Health.

  • NIH IBC registration number: [Confirm]
  • Institutional Official: Sameer Huda, Director of Business Operations

IBC meeting minutes

NIH asks institutions to make IBC meeting minutes available to the public. Approved minutes from meetings that reviewed Provecta research are posted below once available. Some information may be redacted to protect proprietary, confidential or personal details.

Meeting dateMinutes
No meetings yetn/a

Contact and public access

To request IBC minutes or information about attending an IBC meeting, contact:

Provecta Research Network
4200 Twelve Oaks Place, Houston, Texas 77027
Email: siqbal@provectaresearch.org